HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recognition and identification of UV-absorbing leachables in EPREX pre-filled syringes: an unexpected occurrence at a formulation-component interface.

Abstract
During the period of 1998 to 2002, there was an increase in the incidence of antibody-positive pure red cell aplasia (PRCA) in patients receiving subcutaneous administration of EPREX (epoetinum alfa). As part of the investigation of this event, the aqueous formulation containing polysorbate 80, introduced in 1998, facilitated the leaching of small-molecule, aromatic compounds from the uncoated rubber syringe stoppers. The leachables were identified using Liquid Chromatography-Mass Spectroscopy, Electrospray Ionisation-MS/MS, Dithiothreitol reduction, and Hydrogen/Deuterium exchange. The major leachable was identified as a dialkylphenol disulfide, and the majority of the remaining peaks were identified as structural variants containing different numbers of sulfur atoms in the sulfide bridge. In this report, we describe the strategies and experimental designs that were used to overcome the analytical challenges and that led to successful structural identification of the leachables in EPREX pre-filled syringes with uncoated syringe stoppers.
AuthorsJames Pang, Tim Blanc, John Brown, Steven Labrenz, Annabelle Villalobos, Anneli Depaolis, Srinivas Gunturi, Steve Grossman, Peter Lisi, George A Heavner
JournalPDA journal of pharmaceutical science and technology (PDA J Pharm Sci Technol) 2007 Nov-Dec Vol. 61 Issue 6 Pg. 423-32 ISSN: 1079-7440 [Print] United States
PMID18410043 (Publication Type: Journal Article)
Chemical References
  • Hematinics
  • Plastics
  • Recombinant Proteins
  • Erythropoietin
  • Epoetin Alfa
Topics
  • Chemistry, Pharmaceutical
  • Chromatography, High Pressure Liquid
  • Drug Contamination
  • Drug Packaging
  • Epoetin Alfa
  • Erythropoietin (adverse effects, analysis, radiation effects)
  • Gas Chromatography-Mass Spectrometry
  • Hematinics (adverse effects, analysis, radiation effects)
  • Plastics
  • Recombinant Proteins
  • Red-Cell Aplasia, Pure (chemically induced)
  • Syringes
  • Ultraviolet Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: